D. I. Valishaeva

Plant-Derived DPP-4 Inhibitors in Cardiometabolic Diseases: A Critical Evaluation of the Evidence Base and Priorities for Kazakhstan

The increasing prevalence of obesity, type 2 diabetes mellitus, and associated cardiometabolic complications has intensified the challenge of effectively controlling disturbances in carbohydrate metabolism and highlighted the need for new therapeutic targets and approaches. One promising target is the enzyme DPP-4, whi...